| parent | CHEM | LP7786-9 |
| child | Acute kidney injury risk | LP266748-5 |
| child | Alzheimer's disease risk | LP428141-8 |
| child | Kidney failure 2Y risk | LP248942-7 |
| child | Kidney failure 5Y risk | LP248943-5 |
| child | Advanced oxidation protein products | LP65127-0 |
| child | Cardiac heart disease risk | LP96138-0 |
| child | Fluorescence polarization | LP30815-2 |
| child | Horowitz index | LP65891-1 |
| child | Interpretation | LP21032-5 |
| child | LDL apheresis procedure | LP71315-3 |
| child | Lipid risk factors | LP63638-8 |
| child | Lipoprotein goals | LP89585-1 |
| child | Metabolic syndrome | LP64993-6 |
| child | Neural tube defect risk | LP62865-8 |
| child | Nitroprusside reacting substances | LP30646-1 |
| child | Ova1 test | LP111484-4 |
| child | Prostate cancer risk | LP62863-3 |
| child | Hepatocellular carcinoma risk | LP421240-5 |
| child | Protein feed time | LP63625-5 |
| child | Fetal trisomy 13 risk | LP99499-3 |
| child | Trisomy 18 risk | LP36653-1 |
| child | Trisomy 18+Trisomy 13 risk | LP133973-0 |
| child | Trisomy 21 risk | LP36654-9 |
| child | Trisomy 21+Trisomy 18 risk | LP63634-7 |
| child | Rivalta test | LP426321-8 |
| child | Sweat analysis specialist review | LP436369-5 |
| PartDisplayName | en-US | General terms |
LOINC Version: 2.77
FHIR